The antidepressant debate and ethically defensible placebo-controlled trials.
Bibliographic record
Abstract
A basic tenet of biological psychiatry is that place bo-controlled, randomized drug trials under double blind have shown that antidepressants exert pharmacological efficacy-in other words, that they induce specific and measurable drug effects on research subjects. But there is ongoing dissention about whether pharmacological efficacy has been established reliably by these trials. The antidepressant debate indicates a split in the expert clinical community about the size of the drug/placebo difference and whether the mechanisms that produce it stem from the subjects' expectation of benefit or from the intervention's pharmacological prop erties. A basic tenet of research ethics is that if standard effective treatments exist, then clinical equipoise requires their use as active controls against which novel, nonvali dated treatments are tested. Substituting a placebo for an effective treatment in the control arm of a trial does not maintain this duty, as it exposes research subjects to an intervention that is known to be inferior. Defenders of clinical equipoise argue that conducting a trial is not an invitation to practice substandard medicine.' They have also argued that legal liability concerns might be raised about placebo-controlled trials of antidepressants.2 These ethical and legal concerns can be assessed with reference to cases in which clinical equipoise permits placebo-controlled trials. Given the recurring questions about whether the drug/placebo difference results from specific biological effects of antidepressants or from fac tors introduced by placebo response that have not been adequately excluded, I think a plausible argument can be made that clinical equipoise would permit the use of active placebo controls in the clinical trials that test them. This argument can be abbreviated to three premises and a conclusion. The first premise is that placebo con trols for drug trials are ethically defensible and scientifi cally justified when we have evidence leading to a rea sonable concern that a standard treatment might only work because of expectancy enhanced by side effects i.e., by enhanced placebo effects. The second premise is that this evidence must be endorsed by at least a respectable minority of the expert clinical community. Premise three asserts that a respectable minority of the expert clinical community endorses evidence leading to a reasonable concern that standard antidepressants might only work by enhanced placebo effects. If these premises are sound, then one can conclude that placebo controls for antidepressant trials are ethically defensible and sci entifically justified.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.318 | 0.392 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.003 | 0.002 |
| Bibliometrics | 0.002 | 0.002 |
| Science and technology studies | 0.004 | 0.046 |
| Scholarly communication | 0.008 | 0.015 |
| Open science | 0.004 | 0.005 |
| Research integrity | 0.041 | 0.037 |
| Insufficient payload (model declined to judge) | 0.005 | 0.002 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".